Non-stenotic fibro-calcific aortic valve as a predictor of myocardial infarction recurrence.
Veronika A MyasoedovaMattia ChiesaNicola CosentinoBonomi AliceLudergnani MonicaMichele BozziVincenza ValerioDonato MoschettaIlaria MassaiuValentina MantegazzaGiancarlo MarenziPoggio PaoloPublished in: European journal of preventive cardiology (2024)
AVSc is a crucial variable for identifying AMI patients at high risk of recurrent AMI and its presence should be considered when assessing the management of AMI patients. The inclusion of AVSc in risk stratification models may improve the accuracy of predicting the likelihood of recurrent AMI, leading to more personalized treatment decisions.
Keyphrases
- acute myocardial infarction
- aortic valve
- end stage renal disease
- ejection fraction
- transcatheter aortic valve replacement
- aortic stenosis
- transcatheter aortic valve implantation
- aortic valve replacement
- left ventricular
- chronic kidney disease
- heart failure
- percutaneous coronary intervention
- peritoneal dialysis
- prognostic factors
- atrial fibrillation
- coronary artery disease
- patient reported